A blood test could help identify men with advanced prostate cancer most likely to benefit from targeted radiotherapy

Medical Xpress - latest medical and health news stories · 43m ago

A blood test could help identify men with advanced prostate cancer who are more likely to experience longer disease control following targeted radiotherapy, according to research led by The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London and University College London. The findings are published in the journal JAMA Network Open.

Read original article on Medical Xpress - latest medical and health news stories →

A blood test could help identify men with advanced prostate cancer most likely to benefit from targeted radiotherapy

Related news